keyword
Keywords Guidelines for the Treatment o...

Guidelines for the Treatment of Hypothyroidism

https://read.qxmd.com/read/37908997/primary-sellar-neuroblastoma-masquerading-as-a-pituitary-macroadenoma
#21
Nandini Seshan, Simon Hanft, Gayotri Goswami, Arjun Syal
Olfactory neuroblastomas, or esthesioneuroblastomas, are rare and aggressive malignant tumors that typically arise from the olfactory neuroepithelium in the upper nasal cavity. In rare instances, they can be ectopic originating from areas outside the upper nasal cavity such as the sellar region. These tumors, also known as primary sellar neuroblastomas, may be mistaken for pituitary macroadenomas. We present a rare case of a primary sellar neuroblastoma in a 30-year-old woman with a prior diagnosis of presumed prolactinoma, status post transsphenoidal resection, with residual visual deficits, who presented with worsening vision and headaches...
July 2023: JCEM Case Rep
https://read.qxmd.com/read/37897184/optimizing-levothyroxine-treatment-for-subclinical-hypothyroidism-during-pregnancy
#22
REVIEW
Ulrike Gottwald-Hostalek, George J Kahaly
The onset of pregnancy places additional stress of the thyroid gland, which must produce additional thyroid hormones to support the developing foetus. Hypothyroidism, including subclinical hypothyroidism (SCH), may appear de novo at this time, or existing thyroid disease may become more severe. Accordingly, SCH is a relatively common complication of up to about 3% of pregnancies, with higher rates in some areas. There is strong evidence from systematic reviews and meta-analyses that uncontrolled SCH is associated with an increased risk of adverse pregnancy outcomes, including miscarriage, preeclampsia, and gestational diabetes...
October 28, 2023: Current Medical Research and Opinion
https://read.qxmd.com/read/37848158/large-method-differences-for-free-thyroid-hormone-assays-in-the-hyperthyroid-range-can-affect-assessment-of-hyperthyroid-status-comparison-of-abbott-alinity-to-roche-cobas-siemens-centaur-and-equilibrium-dialysis-lc-ms-ms
#23
JOURNAL ARTICLE
Alexander Bauer Westbye, Finn Erik Aas, Sandra R Dahl, Svetlana N Zykova, Oskar Kelp, Louise K Dahll, Per M Thorsby
BACKGROUND: Free T4 (FT4) determination is one of the most commonly performed biochemical tests in endocrinology. Treatment of thyroid dysfunctions is adjusted based on the severity of symptoms and biochemical test results. For Graves' hyperthyroidism, clinical guidelines recommend using FT4 as a (rough) guide to dose antithyroid drugs, together with other clinical information. It is well known that different platforms and methods give different FT4 results; however, large non-linear method differences at high FT4 concentrations are less well recognized...
October 15, 2023: Clinical Biochemistry
https://read.qxmd.com/read/37818087/effect-of-thyroid-hormone-replacement-treatment-on-cardiac-diastolic-function-in-adult-patients-with-subclinical-hypothyroidism-a-meta-analysis
#24
Gejing Liu, Man Ren, Yingshi Du, Ruoyu Zhao, Yu Wu, Yongming Liu, Liang Qi
BACKGROUND: Although subclinical hypothyroidism (SCH) is related to abnormalities in left ventricular diastolic function, the use of levothyroxine as a regular treatment remains debatable. This meta-analysis aimed to determine whether thyroid hormone replacement therapy affects cardiac diastolic function in patients with SCH as measured by echocardiography. METHODS: This meta-analysis included a search of the EMBASE, PubMed, Web of Science, and Cochrane Library databases from their inception to May 18, 2023, for studies analyzing cardiac morphology and functional changes in patients with SCH before and after thyroid hormone replacement...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/37782426/immune-related-adverse-events-in-patients-with-lung-cancer
#25
REVIEW
Guilherme Sacchi de Camargo Correia, Tanmayi Pai, Shenduo Li, Dana Connor, Yujie Zhao, Yanyan Lou, Rami Manochakian
PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICI) have been widely adopted for the treatment of lung cancer since receiving first U.S Food and Drug Administration (FDA) approval in 2015. However, along with their use, the occurrence of immune-related adverse events (irAEs) has presented a challenge for both patients and oncology providers. In this manuscript, we reviewed the clinical trials that led to the approval of ICI by the FDA for the treatment of lung cancer between 2015 and 2023 to establish the frequency of irAEs in this patient population...
October 2, 2023: Current Oncology Reports
https://read.qxmd.com/read/37773072/use-of-thyroid-hormones-in-hypothyroid-and-euthyroid-patients-a-2022-thesis-questionnaire-survey-of-members-of-the-latin-american-thyroid-society-lats
#26
JOURNAL ARTICLE
Jessica F Cassemiro, Veronica Ilera, Stella Batalles, Adriana Reyes, Endre V Nagy, Enrico Papini, Petros Perros, Laszlo Hegedüs, Helton Estrela Ramos
PURPOSE: Inconsistencies in the medical management of hypothyroidism have been reported between endocrinologists in different countries. This study aimed to identify the attitudes of Latin America thyroid specialists towards the use of thyroid hormones. METHODS: Online survey of members of the Latin America Thyroid Society. RESULTS: 81/446 (18.2%) completed the questionnaire. Levothyroxine (LT4) was the initial treatment of choice for all respondents...
September 29, 2023: Thyroid Research
https://read.qxmd.com/read/37758506/autoimmune-disease-in-turner-syndrome-in-sweden-an-up-to-25-years%C3%A2-controlled-follow-up-study
#27
JOURNAL ARTICLE
Sabine Naessén, Malin Eliasson, Kerstin Berntorp, Margareta Kitlinski, Penelope Trimpou, Emily Amundson, Sofia Thunström, Bertil Ekman, Jeanette Wahlberg, Anders Karlsson, Magnus Isaksson, Ingrid Bergström, Carina Levelind, Inger Bryman, Kerstin Landin-Wilhelmsen
CONTEXT: Turner syndrome (TS) is the most common chromosomal aberration in women; it is the result of structural or numeric abnormalities in the X chromosome. Autoimmune hypothyroidism has been recognized as one of the more prominent disorders associated with TS. OBJECTIVE: To study the prevalence of autoimmune diseases in TS. DESIGN AND SETTING: A cross sectional, longitudinal, 25-year follow-up study of patients from adult Turner Centers at the University Hospitals, Sweden...
September 27, 2023: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/37740543/tsh-and-ft4-reference-interval-recommendations-and-prevalence-of-gestational-thyroid-dysfunction-quantification-of-current-diagnostic-approaches
#28
JOURNAL ARTICLE
Joris A J Osinga, Arash Derakhshan, Ulla Feldt-Rasmussen, Kun Huang, Tanja G M Vrijkotte, Tuija Männistö, Judit Bassols, Abel López-Bermejo, Ashraf Aminorroaya, Marina Vafeiadi, Maarten A C Broeren, Glenn E Palomaki, Ghalia Ashoor, Liangmiao Chen, Xuemian Lu, Peter N Taylor, Fang-Biao Tao, Suzanne J Brown, Georgiana Sitoris, Lida Chatzi, Bijay Vaidya, Polina V Popova, Elena A Vasukova, Maryam Kianpour, Eila Suvanto, Elena N Grineva, Andrew Hattersley, Victor J M Pop, Scott M Nelson, John P Walsh, Kypros H Nicolaides, Mary E D'Alton, Kris G Poppe, Layal Chaker, Sofie Bliddal, Tim I M Korevaar
CONTEXT: Guidelines recommend use of population- and trimester-specific TSH and FT4 reference intervals (RIs) in pregnancy. Since these are often unavailable, clinicians frequently rely on alternative diagnostic strategies. We sought to quantify the diagnostic consequences of current recommendations. METHODS: We included cohorts participating in the Consortium on Thyroid and Pregnancy. Different approaches were used to define RIs: a TSH fixed upper limit of 4.0 mU/L (fixed limit approach), a fixed subtraction from the upper limit for TSH of 0...
September 22, 2023: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/37723959/a-novel-development-of-levothyroxine-sodium-orodispersible-mini-tablets-for-the-treatment-of-pediatrics-hypothyroidism
#29
JOURNAL ARTICLE
Cecilia Henestrosa, Camila Olivera, Sabrina Flor, Silvia Lucangioli, Ariel Vacatello, Claudia A Ortega, Laura S Favier, Diego A Cifuente
BACKGROUND: In pediatrics, developing new pharmaceutical forms that offer safety and efficacy is crucial to improve pediatric pharmaceutical care. Orodispersible tablets do not require swallowing because orodispersible tablets dissolve quickly in the mouth, reducing the risk of choking and making medication administration safer and more straightforward. There is no solid dosage form in the pharmaceutical market offering a unit dose of Levothyroxine for pediatric hypothyroidism patients...
September 8, 2023: Recent advances in drug delivery and formulation
https://read.qxmd.com/read/37686597/hypothyroidism-following-radiotherapy-for-head-and-neck-cancer-a-systematic-review-of-the-literature-and-opportunities-to-improve-the-therapeutic-ratio
#30
REVIEW
Michael K Rooney, Lauren M Andring, Kelsey L Corrigan, Vincent Bernard, Tyler D Williamson, Clifton D Fuller, Adam S Garden, Brandon Gunn, Anna Lee, Amy C Moreno, William H Morrison, Jack Phan, David I Rosenthal, Michael Spiotto, Steven J Frank
(1) Background: Radiotherapy (RT) is a central component for the treatment of many head and neck cancers. In this systematic review of the literature, we aimed to characterize and quantify the published evidence on RT-related hypothyroidism, including estimated incidence, clinical risk factors, and dosimetric parameters that may be used to guide clinical decision making. Furthermore, we aimed to identify potential areas of improvement in the prevention and clinical management of RT-induced hypothyroidism, including the role of modern advanced therapeutic techniques...
August 29, 2023: Cancers
https://read.qxmd.com/read/37623020/percutaneous-radiofrequency-ablation-of-thyroid-carcinomas-ineligible-for-surgery-in-the-elderly
#31
Pierre Yves Marcy, Marc Tassart, Jean-Guillaume Marchand, Juliette Thariat, Alain Bizeau, Edouard Ghanassia
Thirty to 50% of differentiated thyroid carcinomas include papillary thyroid microcarcinomas (mPTC). Most of these tumors remain clinically silent, have a bright prognosis and a disease-specific mortality <1%. Surgery has been recommended as first line-treatment by current guidelines, the standard treatment being lobectomy. However, surgery has some drawbacks, including potential recurrent laryngeal nerve paralysis, hypothyroidism, hypoparathyroidism, in -patient basis hospital stay, lifelong medication, scarring of the neck, and general anesthesia related risks...
August 6, 2023: Current Oncology
https://read.qxmd.com/read/37593221/efficacy-and-safety-of-sintilimab-plus-bevacizumab-in-metastatic-nasopharyngeal-carcinoma-after-failure-of-platinum-based-chemotherapy-an-open-label-phase-2-study
#32
JOURNAL ARTICLE
Nian Lu, Yao-Fei Jiang, Wei-Xiong Xia, Ying Huang, Chuan-Miao Xie, Cheng Xu, Yan-Fang Ye, Guo-Ying Liu, Wei-Xin Bei, Liang-Ru Ke, Wang-Zhong Li, Cheng Zhang, Xin Wang, Qin Liu, Xi Chen, Zi-Xiong Chen, Changqing Xie, Hu Liang, Yan-Qun Xiang
BACKGROUND: There are limited treatment options for patients with metastatic nasopharyngeal carcinoma (mNPC) after failure of platinum-based chemotherapy. In this trial, we assessed the efficacy and safety of sintilimab plus bevacizumab in patients with mNPC where platinum-based chemotherapy has been ineffective. METHODS: This was a single-centre, open-label, single-arm, phase 2 trial in Guangzhou, China for patients with mNPC progressed after at least one line of systemic therapy...
August 2023: EClinicalMedicine
https://read.qxmd.com/read/37550859/management-of-subclinical-hypothyroidism-a-focus-on-proven-health-effects-in-the-2023-korean-thyroid-association-guidelines
#33
JOURNAL ARTICLE
Eu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
Subclinical hypothyroidism (SCH) is characterized by elevated thyroid-stimulating hormone (TSH) and normal free thyroxine levels. The Korean Thyroid Association recently issued a guideline for managing SCH, which emphasizes Korean-specific TSH diagnostic criteria and highlights the health benefits of levothyroxine (LT4) treatment. A serum TSH level of 6.8 mIU/L is presented as the reference value for diagnosing SCH. SCH can be classified as mild (TSH 6.8 to 10.0 mIU/L) or severe (TSH >10.0 mIU/L), and patients can be categorized as adults (age <70 years) or elderly (age ≥70 years), depending on the health effects of LT4 treatment...
August 2023: Endocrinology and Metabolism
https://read.qxmd.com/read/37545125/effects-of-treating-subclinical-hypothyroidism-in-pregnancy-in-india-are-we-treating-too-many-for-little-gain-a-retrospective-cohort-study
#34
JOURNAL ARTICLE
Uma Ram, Mathangi Thirunavukkarasu, Krishna Shyam, Yonas Ghebremichael-Weldeselassie, Nithya Sukumar, Ponnusamy Saravanan
OBJECTIVE: To assess the impact of treatment of subclinical hypothyroidism (SCH) on short-term pregnancy outcomes. METHOD: Data from 4526 consecutive women with singleton pregnancies who delivered between January 2015 and December 2017 were analyzed. SCH was defined as a thyroid-stimulating hormone (TSH) level between 2.5 and 10 mU/mL with normal free thyroxine. Of those with SCH, some were treated but others were not. These two groups were compared using χ2 and Student t tests for categorical and continuous variables, respectively...
August 6, 2023: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/37501790/treating-subclinical-hypothyroidism-in-individuals-with-or-without-mental-health-problems-a-delphi-based-expert-consensus-study-in-two-countries
#35
JOURNAL ARTICLE
Ingrid Lieber, Christina Maria Van Der Feltz-Cornelis, Salman Razvi, Andrew S Moriarty, Scott Wilkes, Michael Ott, Julie Mannchen, Mats Eliasson, Ursula Werneke
BACKGROUND: Subclinical hypothyroidism (SCH) is a common endocrine problem with prevalence estimates between 4% and 20%. Symptoms are often non-specific but can substantially affect well-being leading to repeated medical consultations. The effect of thyroid hormone replacement therapy (THRT) in patients with SCH remains uncertain. Current guidelines, limited by the lack of high-quality evidence, have been controversial with limited adherence in clinical practice. METHODS: Three-round modified Delphi method to establish consensus regarding diagnosis and treatment of individuals with SCH with and without affective disorder or anxiety, conducted with clinicians from three specialties, general practice, endocrinology and psychiatry, and two countries, Sweden and the United Kingdom...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/37391043/levothyroxine-dosing-in-older-adults-recommendations-derived-from-the-baltimore-longitudinal-study-of-aging
#36
JOURNAL ARTICLE
Colleen Gavigan, Enoch J Abbey, John McGready, Eleanor M Simonsick, Jennifer S Mammen
OBJECTIVE: As thyroid hormone metabolism slows with advancing age, treatment dosing requirements change. Guidelines recommend titration from a low starting dose for older adults with hypothyroidism while providing weight-based estimates for younger populations. However, rapid replacement may be appropriate with acute onset of overt hypothyroidism. Therefore, a weight-based recommendation specific to older adults is needed. METHODS: We determined mean levothyroxine dose using actual and ideal body weight (IBW) ratios for the outcome of euthyroid on therapy relative to assay-specific and proposed age-specific ranges for independently living participants aged ≥65 years in the Baltimore Longitudinal Study of Aging...
June 28, 2023: Endocrine Practice
https://read.qxmd.com/read/37327351/demographic-healthcare-access-and-dietary-factors-associated-with-thyroid-hormone-treatments-for-hypothyroidism
#37
JOURNAL ARTICLE
Matthew D Ettleson, Sabrina Ibarra, Wen Wan, Sarah Peterson, Neda Laiteerapong, Antonio C Bianco
CONTEXT: Clinical guidelines have recommended a trial of liothyronine (LT3) with levothyroxine (LT4) in select patients with hypothyroidism. However, little is known about the real-world use LT3 and desiccated thyroid extract (DTE) and the characteristics of patients treated with LT3 and DTE. OBJECTIVES: 1) determine national trends of new LT4, LT3, and DTE prescriptions in the US; 2) determine whether sociodemographic, healthcare access, and dietary factors are associated with different thyroid hormone (TH) therapies...
June 16, 2023: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/37291743/diagnosis-and-management-of-thyroid-disease-during-pregnancy-and-postpartum-revised-korean-thyroid-association-guidelines
#38
JOURNAL ARTICLE
Hwa Young Ahn, Ka Hee Yi
Thyroid hormone plays a critical role in fetal growth and development, and thyroid dysfunction during pregnancy is associated with several adverse outcomes, such as miscarriage and preterm birth. In this review, we introduce and explain three major changes in the revised Korean Thyroid Association (KTA) guidelines for the diagnosis and management of thyroid disease during pregnancy: first, the normal range of thyroid-stimulating hormone (TSH) during pregnancy; second, the treatment of subclinical hypothyroidism; and third, the management of euthyroid pregnant women with positive thyroid autoantibodies...
June 9, 2023: Endocrinology and Metabolism
https://read.qxmd.com/read/37263963/investigation-and-management-of-recurrent-pregnancy-loss-a-comprehensive-review-of-guidelines
#39
REVIEW
Sonia Giouleka, Ioannis Tsakiridis, Elisavet Arsenaki, Ioannis Kalogiannidis, Apostolos Mamopoulos, Evangelos Papanikolaou, Apostolos Athanasiadis, Themistoklis Dagklis
IMPORTANCE: Recurrent pregnancy loss (RPL) is one of the most frustrating clinical entities in reproductive medicine requiring not only diagnostic investigation and therapeutic intervention, but also evaluation of the risk for recurrence. OBJECTIVE: The aim of this study was to review and compare the most recently published major guidelines on investigation and management of RPL. EVIDENCE ACQUISITION: A descriptive review of guidelines from the Royal College of Obstetricians and Gynaecologists, the European Society of Human Reproduction and Embryology, the American Society for Reproductive Medicine, the French College of Gynecologists and Obstetricians, and the German, Austrian, and Swiss Society of Gynecology and Obstetrics on RPL was carried out...
May 2023: Obstetrical & Gynecological Survey
https://read.qxmd.com/read/37261184/association-of-vitamin-d-status-with-metabolic-syndrome-and-its-individual-risk-factors-a-cross-sectional-study
#40
JOURNAL ARTICLE
Monika Pathania, Minakshi Dhar, Arjun Kumar, Sarama Saha, Rashmi Malhotra
Background Vitamin D deficiency has been associated with metabolic syndrome and its related outcomes, including type 2 diabetes mellitus, cardiovascular disease, myocardial infarction, and stroke. However, studies in Indian populations have provided conflicting results. Methods This single-center cross-sectional study was conducted in a tertiary care hospital in north India to determine the prevalence of vitamin D deficiency in patients with metabolic syndrome and to study the correlations of individual components of metabolic syndrome with 25 hydroxy vitamin D levels...
April 2023: Curēus
keyword
keyword
114864
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.